Xiaolei Hu
Zhanjiang, 524001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Environmental nanoplastics exert dual effects: promoting tumor progression in cancer cells while inducing pyroptosis in normal esophageal epithelium.
Journal: International immunopharmacology
Published: October 09, 2025
A two-stage robust non-intrusive load monitoring method against unknown waveform distortions.
Journal: Scientific reports
Published: October 06, 2025
Ultrasound-guided sclerotherapy with 76% meglumine diatrizoate for bilateral chylothorax after thyroid cancer surgery: a case report.
Journal: Frontiers in oncology
Published: August 12, 2025
17 β-Estradiol inhibits GSDME-mediated pyroptosis in ERα-positive breast cancer cells by promoting GSDME promoter methylation.
Journal: The Journal of steroid biochemistry and molecular biology
Published: March 21, 2025
Dosimetric impacts on height development after radiotherapy for intracranial non-germinomatous germ cell tumors.
Journal: International journal of radiation biology
Published: March 21, 2025
Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer.
Journal: BMC women's health
Published: October 16, 2023
Sauchinone inhibits breast cancer cell proliferation through regulating microRNA-148a-3p/HER-2 axis.
Sauchinone inhibits breast cancer cell proliferation through regulating microRNA-148a-3p/HER-2 axis.
Journal: Thoracic cancer
Published: November 16, 2022
A genomic and transcriptomic study toward breast cancer.
Journal: Frontiers in genetics
Published: July 08, 2022
Additional adjuvant capecitabine in early breast cancer patients: a meta-analysis of randomized controlled trials.
Journal: Future oncology (London, England)
Published: October 25, 2021
MiR-433 reverses chemoresistance to docetaxel by targeting Notch1 in breast cancer cells
Journal: Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Published: July 30, 2018
Erratum to: The expression of CXCL13 and its relation to unfavorable clinical characteristics in young breast cancer.
Journal: Journal of translational medicine
Published: November 17, 2016
MicroRNA-433 targets AKT3 and inhibits cell proliferation and viability in breast cancer.
Journal: Oncology letters
Published: August 28, 2016
Last Updated: 09/26/2026